As for HAS3, it showed significant downregulation in BRCA, KICH, LUAD, PRAD, stomach adenocarcinoma (STAD), thyroid carcinoma (THCA), and SKCM tumors. Here, HAS3 is linked to gastric adenocarcinoma.